George W Liechti

17PUBLICATIONS
29CO-AUTHORS
Innate immunityInfectious agentsArchitecture managementMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 21, 2026
Dysbiosis-induced expansion of AXL-positive inflammatory type 3 dendritic cells triggers preclinical autoimmunity.

|Mar 11, 2026
Characterization of the cell division-associated peptidoglycan amidase AmiA of Chlamydia trachomatis.

Julia Dannenberg, Junghoon Lee, George W Liechti

|Feb 17, 2026
Glutamate metabolism: an essential component for persistence in Staphylococcus aureus.

George W Liechti

|Dec 19, 2025
Chlamydia trachomatis restricts signaling through NOD2 until late in the pathogen's developmental cycle.

Grace Overman, Iris Loeckener, Zachary Williford

|Nov 24, 2025
Characterization of the Cell Division-Associated Peptidoglycan Amidase AmiA of Chlamydia trachomatis.

Julia Dannenberg, Junghoon Lee, George W Liechti

|Jun 12, 2025
Chlamydia trachomatis restricts signaling through NOD2 until late in the pathogen's developmental cycle.

Grace Overman, Iris Loeckener, Zachary Williford

Pageof 3

Frequent Collaborators

5 joint publications

Anthony T Maurelli

2 joint publications

Raghuveer Singh

2 joint publications

Scot P Ouellette

1 joint publications

Grozdan Cvijetic